ASX Share rice
Fri 14 May 2021 - 09:00:pm (Sydney)

AVE Share Price

AVECHO BIOTECHNOLOGY LIMITEDAVEPharmaceuticals, Biotechnology & Life Sciences

AVE Company Information

Name:

Avecho Biotechnology Limited

Sector:

Healthcare

Industry:

Biotechnology

Address:

2A Westall Road Clayton VIC Australia 3168

Phone:

61 3 9002 5000

COO & GM of Animal Health & Nutrition:

Dr. Roksan Libinaki

CEO & Chief Scientific Officer:

Dr. Paul Gavin

Company Sec. & CFO:

Ms. Melanie Jaye Leydin C.A., B.Bus, CA

Company Overview:

Avecho Biotechnology Limited, a biotechnology company, develops, produces, sells, and licenses products using its patented platform technology, Targeted Penetration Matrix (TPM) drug delivery system for the pharmaceutical, animal health, and nutrition industries in Australia and internationally. The company operates through Production, Human Health, and Other segments. It offers TPM and Vital ET products for use in drug delivery and cosmetic formulations; and develops TPM/Oxymorphone and TPM/Oxycodone. The company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. It provides non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 is based in Clayton, Australia.

AVE Share Price Information

Shares Issued:

1.83B

Market Capitalisation:

$29.26M

Revenue (TTM):

$384.63K

Earnings per Share:

$0.001

Operating Margin (TTM):

$-8.86

Return On Assets (TTM):

$-0.49

Return On Equity (TTM):

$-0.71

Quarterly Revenue Growth (YOY):

2.03

Gross Profit(TTM):

$240.91K

Diluted Earnings Per Share (TTM):

$-0.002

AVE CashFlow Statement

CashFlow Date:

2020-12-31

Investments:

$-4,357

Change To Liabilities:

$53.13K

Total Cashflow From Investing Activities:

$-4,357

Net Borrowings:

$-82,503

Net Income:

$-2,634,853

Total Cash From Operating Activities:

$-1,423,960

Depreciation:

$536.63K

Other Cashflow From Investing Activities:

$793

Change To Inventory:

$48.76K

Change To Account Receivables:

$276.32K

Capital Expenditures:

$5.15K

AVE Income Statement

Income Date:

2020-12-31

Income Before Tax:

$-2,634,853

Net Income:

$-2,634,853

Gross Profit:

$240.91K

Operating Income:

$-3,407,016

Other Operating Expenses:

$600.93K

Interest Expense:

$5.93K

Total Revenue:

$384.63K

Cost Of Revenue:

$143.72K

AVE Balance Sheet

Balance Sheet Date:

2020-12-31

Intangible Assets:

$431K

Total Liabilities:

$700.17K

Total Stockholder Equity:

$2.65M

Other Current Liabilities:

$73.38K

Total Assets:

$3.35M

Common Stock:

$232.78M

Other Current Assets:

$238.70K

Retained Earnings:

$-258,661,146

Other Liabilities:

$3.39K

Cash:

$1.87M

Total Current Liabilities:

$603.58K

Property - Plant & Equipment:

$232.99K

Net Tangible Assets:

$2.22M

Total Current Assets:

$2.69M

Net Receivables:

$479.12K

Short-Term Investments:

$663.99K

Inventory:

$100.01K

Accounts Payable:

$110.31K

Short-Term Investments:

$663.99

Non Current Liabilities Total:

$96.59K

AVE Share Price History

AVE News

08 Dec, 2020
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...